| Drug Class: |
Growth hormone secretagogue peptide (selective ghrelin receptor agonist) |
| Molecular Formula: |
C38H49N9O5 |
| Molecular Weight: |
~711.9 g/mol |
| Form: |
Lyophilized peptide (vial) |
| Purity: |
Not specified (typically ≥98% peptide purity for research-grade synthesis) |
| Sequence: |
Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (pentapeptide ghrelin mimetic) |
| Brand: |
British Dragon Pharmaceuticals |
| Substances: |
Ipamorelin |
| Concentration: |
5mg |
Product Disclaimer: Research Purposes Only
This product is intended strictly for laboratory research and in vitro analysis. It is not approved for human or animal use. Any form of internal administration is prohibited by law. Handling should be limited to qualified and licensed professionals. This item is not classified as a pharmaceutical, dietary supplement, or cosmetic product. For educational and scientific research use only.
Ipamorelin 5mg – Growth Hormone Secretagogue Research Peptide by British Dragon Pharma
Introduction and Overview
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue, studied in laboratory and preclinical research for its selective interaction with the growth hormone secretagogue receptor (GHS-R1a). It is frequently used as a model compound in endocrine and molecular biology to investigate pulsatile hormone signaling and receptor-mediated intracellular communication.
In experimental settings, Ipamorelin is evaluated for its receptor selectivity, signaling efficiency, and downstream activation of endocrine pathways involved in growth hormone regulation. Research focuses on mechanistic signaling behavior rather than physiological outcomes or clinical implications.
Ipamorelin is strictly intended for research purposes only and is not approved for human consumption, therapeutic use, or diagnostic application.
Biological Relevance
Ghrelin Receptor (GHS-R1a) Signaling
Ipamorelin interacts with the growth hormone secretagogue receptor (GHS-R1a), a G protein-coupled receptor involved in endocrine regulation and hypothalamic signaling. Activation of this receptor triggers intracellular cascades including:
- cAMP/PKA signaling pathways – second messenger systems regulating transcriptional activity
- PLC/IP3 signaling – calcium-mediated intracellular communication
- MAPK/ERK pathways – involved in gene expression and signal integration
- Calcium-dependent signaling cascades – regulating hormone secretion dynamics
Selective Growth Hormone Secretion Research
Ipamorelin is widely studied for its selective activation of growth hormone release pathways in comparison to other secretagogue systems. Laboratory research examines:
- Pituitary somatotroph signaling dynamics
- Pulsatile endocrine secretion mechanisms
- Receptor selectivity and ligand affinity patterns
- Neuroendocrine feedback regulation systems
These studies are closely associated with endocrine research and neurocognitive research.
Metabolic and Cellular Communication Pathways
Experimental models involving Ipamorelin also examine downstream metabolic signaling networks, including:
- GH/IGF-1 axis signaling pathways – endocrine communication systems
- mTOR signaling – nutrient-sensitive regulatory network
- AMPK pathways – cellular energy sensing mechanisms
These pathways are commonly studied in metabolic research and longevity research.
Research Applications and Experimental Investigation
Receptor Binding and Selectivity Studies
Ipamorelin is used in laboratory assays to evaluate ligand-receptor binding affinity, specificity, and activation kinetics at the GHS-R1a receptor.
Neuroendocrine Signaling Models
Researchers investigate hypothalamic-pituitary communication pathways and pulsatile hormone release dynamics in controlled experimental systems.
Intracellular Signal Transduction Analysis
Studies focus on second messenger systems such as cAMP and calcium-dependent signaling pathways involved in endocrine regulation.
Internal and External Research Connections
Ipamorelin-related research intersects with multiple biomedical disciplines. In musculoskeletal research, growth hormone signaling pathways are studied in structural and cellular communication models. In cardiovascular research, endocrine signaling is evaluated in vascular regulation systems.
Additional overlap exists with regeneration research, where peptide-mediated signaling pathways are analyzed in cellular repair models, and immune support research, which investigates hormonal modulation of immune signaling networks.
Researchers access peer-reviewed literature through PubMed, the NCBI database, and institutional resources from the National Institutes of Health.
Product Information
Compound Details
- Product Title: Ipamorelin
- Active Substance: Ipamorelin
- Concentration: 5mg
- Pack Size: Vial
- Manufacturer: British Dragon Pharma
Compliance and Disclaimer
Ipamorelin is strictly intended for laboratory and preclinical research purposes only. It is not approved for human consumption, medical use, or diagnostic application by regulatory authorities including the U.S. Food and Drug Administration.
No claims regarding safety, efficacy, or physiological outcomes are made or implied. All research involving peptide compounds must follow institutional biosafety standards, ethical laboratory protocols, and applicable regulatory frameworks.
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a synthetic growth hormone secretagogue studied in laboratory environments for its selective interaction with GHS-R1a receptors and endocrine signaling pathways.
Which pathways are commonly studied with Ipamorelin?
Research focuses on cAMP/PKA signaling, PLC/IP3 pathways, calcium-dependent signaling, MAPK/ERK cascades, and GH/IGF-1 axis regulation.
Is Ipamorelin approved for human use?
No. Ipamorelin referenced here is strictly for research purposes only and is not approved for therapeutic or clinical applications.
Which scientific fields study growth hormone secretagogues?
Relevant disciplines include endocrine research, metabolic research, neurocognitive research, and longevity research.
Where can scientific literature on ghrelin receptor signaling be found?
Peer-reviewed sources are available via PubMed, NCBI, and institutional publications from the NIH.
References
PubMed – Ipamorelin and Ghrelin Receptor Research
NCBI – Endocrine Regulation and Pituitary Signaling
NCBI – Cellular Signal Transduction Pathways
NIH – Hormonal and Neuroendocrine Research Resources
FDA – Laboratory Research Substance Guidance
WHO – Biomedical Research and Laboratory Standards
Ipamorelin – FAQ
✔️ What is Ipamorelin?
Ipamorelin is a selective growth hormone secretagogue peptide that stimulates the natural release of Human Growth Hormone (HGH) from the pituitary gland.
✔️ How does Ipamorelin work?
It binds to ghrelin receptors (GHS-R1a), triggering pulsatile HGH secretion without significantly affecting cortisol or prolactin levels.
✔️ What are the main research effects of Ipamorelin?
Commonly studied effects include improved recovery, enhanced sleep quality, increased lean muscle support, and improved fat metabolism.
✔️ Why is Ipamorelin considered selective?
It is known for its high receptor specificity, meaning it primarily stimulates growth hormone release with minimal hormonal disruption.
✔️ How should Ipamorelin be stored?
Store the Ipamorelin vial in a refrigerator at 2–8°C (36–46°F) and protect it from heat, light, and moisture to maintain stability and potency.
✔️ What happens after reconstitution?
After mixing with sterile bacteriostatic water, it must be refrigerated and used within the recommended timeframe to preserve effectiveness.
✔️ Is Ipamorelin safe?
Ipamorelin is a research peptide, generally considered well-tolerated in studies, but should be used in a controlled research environment.
✔️ Can Ipamorelin help with fat loss research?
Yes, it may support lipolysis (fat breakdown) indirectly through increased growth hormone release and metabolic activity.
✔️ Does Ipamorelin improve sleep?
Research suggests it may enhance deep sleep cycles, which are closely linked to natural HGH secretion and recovery processes.
✔️ Are there side effects of Ipamorelin?
Possible mild effects include temporary fatigue, headache, dizziness, or injection site irritation.
✔️ How is Ipamorelin typically administered?
It is commonly used via subcutaneous injection, often timed in the evening to align with natural HGH rhythms.
✔️ Where can I buy authentic Ipamorelin?
Always source from trusted suppliers such as verified peptide vendors or reputable research chemical distributors to ensure purity, authenticity, and quality control.
Ipamorelin – Storage and Safety
The correct storage and handling of Ipamorelin is essential to preserve its peptide purity, growth hormone secretagogue activity, and structural stability. As a highly sensitive synthetic peptide, Ipamorelin requires consistent environmental control to ensure long-term effectiveness and reliable performance outcomes.
Optimal Storage Conditions
To maintain maximum potency, Ipamorelin vials must always be stored in a refrigerated environment between 2°C and 8°C (36°F–46°F). Stable cold conditions help protect the integrity of the growth hormone releasing peptide chain, preventing degradation caused by heat exposure, light, or temperature fluctuations.
The vial should remain in its original sealed packaging, protected from direct sunlight, humidity, and oxygen exposure. Environmental instability can reduce the effectiveness of peptide-based hormone secretagogues, leading to decreased biological activity over time. Freezing is strictly prohibited, as it can permanently damage the molecular structure of Ipamorelin peptides.
Safe Handling Practices
When working with Ipamorelin, strict sterile technique is required to prevent contamination and preserve product quality. Only sterile syringes and properly disinfected preparation tools should be used during reconstitution and administration.
The rubber stopper should always be disinfected before each use, and contact with non-sterile surfaces must be avoided. The vial should not be shaken aggressively, as excessive mechanical force may compromise the stability of the Ipamorelin solution and reduce consistency.
Post-Reconstitution Stability
Once reconstituted, Ipamorelin solution becomes more sensitive and must be continuously refrigerated. Maintaining a stable cold environment is critical to preserve peptide potency and receptor signaling activity. The solution should always be used within the recommended timeframe to ensure optimal effectiveness.
Any visible changes such as cloudiness, discoloration, or particulate formation may indicate degradation, and the product should not be used. Proper adherence to storage timelines ensures reliable growth hormone stimulation support performance.
Safety and Responsibility Notes
Ipamorelin peptides should always be stored securely and kept out of reach of children or unauthorized individuals. Responsible handling is essential to maintain product integrity and prevent misuse.
Following correct Ipamorelin storage protocols ensures long-term stability, preserves peptide quality, and supports consistent outcomes for users incorporating it into structured performance, recovery, or physique-focused routines.